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The aim of this study was to examine, over a period of 1 year, interindividual variations in the most
prominent and representative of the cultivatable microbial populations in the feces of eight healthy
Spanish persons. A number of biochemical variables (enzyme activities and ammonium and short-
chain fatty acid [SCFA] concentrations) thought to be influenced by the GIT microbiota were also
analyzed. Total cultivatable microbial counts ranged from 1010 to 1011 cfu/g of feces. The largest
populations were obligate anaerobes belonging to the Clostridium clusters, followed by species
of bifidobacteria and bacteroides. Coliforms and lactobacilli were found at a more intermediate
level (105–109 cfu/g). The predominant anaerobe populations remained quite constant over time,
but all other microbial groups showed significant interindividual differences. Enzyme profiles were
individual-dependent, but within subjects, moderate to high intersample variations over time were
recorded for some activities. Fecal ammonium concentration was the most unpredictable variable;
this fluctuated widely between individuals and samples. Acetic acid was the most abundant SCFA in
the feces, followed by butyric and propionic acids. SCFA concentrations also varied according to the
individual; some subjects showed specific profiles in terms of SCFA composition or concentration.
The fecal microbial and biochemical parameters studied seemed to be individual-dependent. Most
variables were rather stable over time, while others (e.g., ammonium concentration) varied widely.
KEY WORDS: gastrointestinal microbiology; enzyme activity in feces; short-chain fatty acids; ammonium in feces;
probiotics.
The human gastrointestinal tract (GIT) is colonized soon
after birth by a complex and diverse collection of microbial
species (1, 2). This microbiota influences several biochem-
ical, physiological, and immunological characteristics of
the host (3–5). Due to host-specific differences (age, sex,
physiological state, etc.) or dietary habits, the types and
numbers of microbial populations may be different in dif-
ferent human groups and even between individuals (6–8).
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Current evidence suggests that these microorganisms
may have important metabolic roles (fermentation of
nondigested dietary and endogenous materials, production
of vitamins, absorption of ions), trophic functions (con-
trol of cell proliferation and differentiation, development
and homoeostasis of the immune system), and protective
effects (the barrier effect) (3, 9). Moreover, GIT micro-
biota show a series of important enzyme activities that
can transform food and host-derived components into dif-
ferent metabolites that could be either beneficial or detri-
mental to the host (5, 10). Ascertaining the components
of the GIT microbiota and their individual contribution
to host health is therefore very important, since it might
be plausible to promote or inhibit particular populations
(and their activities) through the use of probiotics and/or
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prebiotics (11). Lactic acid bacteria (including bifidobac-
teria) are thought to have positive and protective effects
on the GIT, thus contributing to the host health (3, 12).
Short-chain fatty acids (SCFAs) are considered among
the most beneficial metabolites produced by the GIT mi-
crobiota. SCFAs (primarily acetic, butyric, and propi-
onic acids) are organic anions formed in the large intes-
tine through the fermentation of carbohydrates (9). These
could be used as a source of energy for other microor-
ganisms or even for the host (13). SCFAs stimulate the
proliferation and differentiation of epithelial cells in the
large and small intestine in vivo (14, 15), inhibiting in
some instances the proliferation of neoplastic cells, which
might contribute to cancer prevention (5, 10, 16). SCFA
concentrations affect the microbial composition of the lu-
men by lowering the pH. A low pH may also help pre-
vent colon cancer through the inhibition of certain bac-
terial enzymes (e.g., bacterial 7-α-dehydroxylases and
β-glucuronidases) (5).
Harmful compounds produced by the GIT microbiota
may include ammonia and products of putrefaction such as
phenol, p-cresol, indol, skatol, and other such compounds
(5). Some of these have been related to a number of gas-
trointestinal malignancies, including colon cancer (17).
Putrefactive substances are formed from amino acids, and
while they do not appear to be carcinogenic by themselves,
they could act as cocarcinogens or cancer promoters (18).
Ammonia is mainly produced by the deamination of amino
acids. This compound has been found to enhance cell pro-
liferation and is a promoter of colon cancer in rats (19).
This paper reports the variations in the size of total
and indicator microbial populations and the changes in
some biochemical variables in the feces of eight healthy
subjects over a period of 1 year. The work was aimed to
an initial characterization of the GIT system from Spanish
people. Variations between and within individuals were
examined and correlations sought with enzyme activities
and concentrations of ammonium and SCFAs. Finally, the
results were compared to those in the literature from other
human communities.
MATERIALS AND METHODS
Sampling and Sample Processing
The selection of donors and sampling was performed as rec-
ommended by the Regional Ethics Committee of the Principality
of Asturias, Spain. The study subjects were four male and four
female volunteers (mean age, 45 years; range, 39 to 56 years).
At approximately monthly intervals fecal samples were collected
from each individual in sterile containers. These were transported
to the laboratory in anaerobic jars containing Anaerocult A (re-
ducing agent; Merck, Darmstadt, Germany). All samples were
processed within 2 hr after deposition in an anaerobic chamber
(Mac500; Down Whitley Scientific, West Yorkshire, UK) con-
taining a 10% H2, 10% CO2, and 80% N2 atmosphere.
Cultured Microbial Counts
Fecal samples were homogenized in a reducing medium con-
taining Brain Heart Infusion (BHI) broth (Merck), 0.5% glucose,
0.5% yeast extract (Merck), 0.25% cysteine (Merck), 10 μg vi-
tamin K1 L−1 (Merck), and 0.02 g hemin L−1 (Sigma Chemical
Co., St. Louis, MO, USA). They were then serially diluted and
plated in duplicate in agar media as follows.
Total Bacterial Counts. These were determined on BHI agar
with 0.5% glucose, 0.5% yeast extract, 0.25% cysteine, vitamin
K1, and hemin. Plates were incubated anaerobically at 37◦C for
up to 5 days.
Clostridia. Clostridia were enumerated on Reinforced
Clostridium Agar (RCA) (Merck) with 20 μg polymixin B ml−1
(Sigma) after incubation under anaerobic conditions at 37◦C for
48 hr.
Bacteroides. The bacteroides group was enumerated on
Esculine Bile Agar (EBA) (Merck) with 100 μg/ml kanamycin
(Sigma) and 7.5 μg vancomycin ml−1 (Sigma). Incubations were
performed in anaerobiosis at 37◦C for 48 hr.
Lactobacilli and Bifidobacteria. Bifidobacteria and lacto-
bacilli counts were made on de Man, Rogosa, and Sharpe (MRS)
agar (Merck) with 0.25% cysteine after anaerobic incubation at
37◦C for 72 hr. Distinction between lactobacilli and bifidobac-
teria was done by microscopic observation.
Enterobacteria and Coliforms. Violet Red Bile Glucose
(VRBG) and Violet Red Bile Lactose (VRBL) agar (Merck)
were used to enumerate enterobacteria and coliforms, respec-
tively, following aerobic incubation for 24 hr at 37◦C.
Enterococci. Enterococci were scored after 24–48 hr of aero-
bic incubation at 44◦C in Slanetz and Bartley (SB) agar (Merck),
a medium containing 10 g triphenyltetrazolium chloride (TTC)
per liter.
Staphylococci. Dilutions were plated on Baird–Parker (BP)
agar (Merck) with 10% tellurite egg yolk solution (Merck) and
aerobically incubated for 24 hr at 37◦C. Black colonies with and
without egg yolk clearing were recorded.
Yeasts and Molds. Sample dilutions were plated on Chlo-
ramphenicol Glucose Agar (CGA) (Merck) and incubated aero-
bically for 3–5 days at 25◦C.
Biochemical Analysis of Feces
Enzymatic Activities. Enzyme activities were assessed by
the semiquantitative API ZYM method (bioMe´rieux, Montalieu-
Vercieu, France). Fresh fecal samples were suspended 1/500 in
distilled water and 65 μl of this suspension was deposited in
each well. All measurements were made according to the man-
ufacturer’s instructions after 4 hr of anaerobic incubation.
Ammonium Concentration. Fecal samples were diluted
1/10 in distilled water and centrifuged for 10 min at 4500 rpm.
The ammonium concentration was then measured using an ion-
selective probe (Crison Instruments SA, Barcelona, Spain).
Identification and Quantification of Short-Chain Fatty
Acids. To identify and quantify SCFAs in the samples, 0.01 g
of feces was supplemented with 0.1 ml of 2-ethyl butyric acid
as an internal standard and acidified with 0.1 ml of 20%formic
acid (v/v). The acidic solution was then extracted with 1 ml of
methanol. The separation and quantification of SCFAs in the
supernatants were accomplished by gas chromatography in a
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PE 8600 Gas Chromatograph (Perkin Elmer, Wellesley, MA,
USA) using na HP-FFAP column (Hewlett–Packard, Palo Alto,
CA, USA). SCFAs were separated over a temperature range of
100–220◦C and detected by flame ionization.
Statistical Analysis
Statistical analysis was performed using SPSS 11.0 soft-
ware for Windows (SPSS Inc., Chicago, IL, USA). Bacterial
counts, organic acid concentrations, and enzyme activity data
were subjected to one-way ANOVA using “individual” as a factor
with eight categories. The least-significant difference test (LSD
test) was used to compare means and significance was set at
P < 0.05.
RESULTS
Microbial Counts
Table 1 shows the average concentrations and standard
deviations of the microbial populations in the feces of
the eight volunteers, as well as a summary of the sta-
tistical analysis. Total cultivatable bacterial counts were
>1010 cfu g−1 in most samples. Representative colonies
from the BHI agar plates used for total counts were genet-
ically classified by sequencing of part of their 16S rRNA
gene and the sequences compared to those on the databases
(data not shown). The largest populations were composed
of strict anaerobes, Gram-positive spore-forming species,
thought to belong to the Clostridium clusters, followed at
a short distance by bifidobacteria and bacteroides species
(Table 1). The most numerous populations of facultative
anaerobes and aerobes were those of lactobacilli, col-
iforms, enterococci, staphylococci, and yeasts and molds
(in decreasing numerical order). Some subjects consis-
tently showed a greater number of coliforms (∼108 cfu
g−1) than lactobacilli (<107 cfu g−1). Furthermore, in two
individuals (L and M), lactobacilli numbers were below
the detection limit (∼105 cfu g−1).
The size of the numerically predominant anaerobe
populations (clostridia, bifidobacteria, and bacteroides)
showed less variation between individuals than did those
of the facultative anaerobe populations (coliforms and
lactobacilli) (Table 1). This suggests that the dominant
populations are more stable, although intersample varia-
tions were recorded. One-way ANOVA indicated the dif-
ferences between individuals in most populations to be
statistically significant, except for the bacteroides.
Biochemical Analysis
Ammonium Concentration. Fecal ammonium con-
centration varied widely between subjects and between
samples. The means and standard deviations for the am-
monium concentrations in the different individuals (mmol
kg−1 wet feces) were as follows: Individual A, 9.5 ± 1.3;
Individual C, 22.3 ± 1.25; Individual E, 14.3 ± 0.7; Indi-
vidual F, 5.8 ± 0.34; Individual G, 14.3 ± 0.74; Individ-
ual H, 6.5 ± 0.57; Individual L, 12.8 ± 0.67; and Individ-
ual M, 9.0 ± 0.53. The ammonium concentration on the
samples and the dispersion of the values are presented in
Figure 1.
Enzyme Activities. Table 2 summarizes the modal en-
zyme values measured in the feces by the API ZYM
system. Five of the 19 activities for which assays were
performed were never detected (lipase C14, cysteine ary-
lamidase, trypsin, α-quimiotrypsin, and α-mannosidase).
Some individuals showed high intersample fluctuations,
which may be related to the semiquantitative nature of
the results provided by the API-ZYM system. However, it
could also be due to variations in activity over the sampling
period (although no tendency was observed). Thereby one-
way ANOVA was not possible.
Personal profiles could be envisioned for at least some
of these subjects. Individual E, for instance, showed
regularly reduced acid phosphatase, naphthol-AS-BI-
phosphohydrolase, α-galactosidase, and β-glucuronidase
activities but strong β-galactosidase activity. Individual F
had Leu- and Val-aminopeptidase activities clearly above
the mean. In contrast, individual H showed lower than
average β-galactosidase and α-glucosidase activities.
SCFA Profiles and Concentrations. Table 3 shows
the average concentrations and standard deviations for
fecal SCFAs. Approximately 50 to 60 mmol of acetic
acid was found per kilogram of wet feces. In most in-
dividuals butyric acid was the second most common
SCFA (5–22 mmol kg−1), followed by propionic acid (5–
20 mmol kg−1). Traces of valeric and isovaleric acids were
seen in all samples, whereas caproic and isobutyric acids
were only detected in samples from certain individuals,
although they were never observed together. Some SCFA
profiles seemed to be rather personal, such as that of indi-
vidual G (characterized by a high caproic acid concentra-
tion) and subject L (in whom butyric and propionic acids
levels were ∼10-fold below that of acetic acid). One-way
ANOVA (when it could be performed) indicated that the
values for most SCFAs (except isovaleric acid) were sig-
nificantly different between individuals.
DISCUSSION
The general microbial picture obtained by culturing on
selective and differential media was one of feces domi-
nated by anaerobic species coexisting with smaller popula-
tions of facultative organisms. This agrees well with previ-
ous culture-based results from experiments performed on
other human communities (6–8). It is also well established
that facultative anaerobic and aerobic microorganisms
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Fig 1. Ammonium concentration in the feces of the different individuals and distribution of the data
throughout the samples.
appear in much lower numbers in feces than do strict anaer-
obes (2, 3, 9). Although less numerous in feces, these pop-
ulations could be dominant in other parts of the GIT (2, 3).
Culture-based analyses have recently been complemented
by several culture-independent molecular techniques (20–
23) which gave very similar results—at least with respect
to the bacterial groups compared.
All populations showed less variation over time (inter-
sample variation) than between individuals (interindivid-
ual variation). These long-term intersample and interindi-
vidual microbial variations were quite in accordance
with those described elsewhere in a short-term follow-up
TABLE 2. MODAL VALUES OF ENZYMATIC ACTIVITIES IN FECAL SAMPLES MEASURED WITH
THE API-ZYM SYSTEM. UNITS OF ACTIVITY ARE EXPRESSED AS MICROMOLES OF
SUBSTRATE HYDROLYZED PER HOUR PER GRAM WET WEIGHT OF FECES
Individual
Enzymatic activity A C E F G H L M
Esterase-lipase (C8) 10 10 10 19 29 29 5 14
Leu-arylamidase 10 5 38 77 10 38 19 31†
Val-arylamidase 10 nd nd 38 nd nd nd nd
Acid phosphatase 58 29 10 38 29 38 19 29
Naphthol-AS-BI-phosphohydrolase 19 19 10 29 19 19 19 29
α–Fucosidase 10 10 10 10 nd 5 5 8*
Alkaline phosphatase 77 77 77 77 77 77 77 77
Esterase C4 19 10 19 29 38 19 19 19
α–Galactosidase 48 38 19 48 29 29 38 38
β–Galactosidase 77 48 77 38 38 29 58 58
β–Glucuronidase 38 77 19 38 58 38 19 34*
α–Glucosidase 58 67 58 38 29 19 48 58
β–Glucosidase 38 38 38 38 77 48 38 29
N -Acetyl-β-glucosaminidase 77 58 38 58 58 48 58 58
Note. nd, not detected. Lipase C14, cysteine arylamidase, trypsin, α-quimiotrypsin, and
α-mannosidase activities were never detected in fecal samples.
*A modal value was not recorded in three samples, so the mean value is presented.
period (24). The greater stability of the numerically pre-
dominant anaerobe populations (clostridia, bifidobacteria,
and bacteroides) compared to the facultative anaerobes is
in agreement with the results of other authors (8, 25, 26).
The most striking difference between the present and
previously published results are the consistently low
bacteroides counts. It was first believed that excessive se-
lectivity of the EBA medium might account for this, how-
ever, similar results were obtained when using a culture-
independent technique based on sequence and analysis
of 16S rDNA libraries using universal bacterial primers
from two selected fecal samples (Delgado and Mayo,
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TABLE 3. MEAN AND STANDARD DEVIATION OF THE DIFFERENT SHORT-CHAIN FATTY ACIDS (SCFAS) DETECTED IN FECES: RESULTS
OF ONE-WAY ANOVA USING “INDIVIDUAL” AS A FACTOR AND MULTIPLE MEANS COMPARISON BY THE LEAST-SIGNIFICANT
DIFFERENCE TEST (P < 0.05) ARE ALSO INDICATED
SCFAs (mmol kg−1 wet feces)
Individual Acetic Butyric Propionic Isobutyric Valeric Isovaleric Caproic
A 61.96 ± 4.7bc 12.67 ± 1.6b 20.48 ± 4.1f nd 1.50 ± 0.5d 0.93 ± 0.5 1.30 ± 1.3
C 63.60 ± 4.8bc 22.54 ± 4.3c 8.80 ± 1.5ab 0.22 ± 0.5 1.30 ± 0.1cd 1.18 ± 0.3 nd
E 52.71 ± 9.1a 13.02 ± 5.1b 11.12 ± 4.1bc 0.16 ± 0.3 0.81 ± 0.7ab 1.17 ± 0.3 nd
F 55.65 ± 6.7ab 20.16 ± 4.0c 18.07 ± 3.8ef nd 1.30 ± 0.2cd 1.14 ± 0.5 0.47 ± 0.8
G 69.80 ± 7.4c 15.18 ± 3.4b 13.58 ± 2.8cd nd 1.47 ± 0.4d 0.98 ± 0.2 6.71 ± 2.3
H 58.34 ± 9.6ab 15.53 ± 6.5b 11.17 ± 4.6bc 0.17 ± 0.9 0.95 ± 0.3ac 1.17 ± 0.4 nd
L 51.07 ± 9.9a 5.58 ± 2.9a 5.85 ± 1.7a nd 0.62 ± 0.2a 0.71 ± 0.1 nd
M 61.52 ± 6.5bc 11.74 ± 1.6b 15.72 ± 1.3de nd 1.26 ± 0.4bcd 1.30 ± 0.9 nd
ANOVA ** *** *** NP ** NS NP
Note. nd, not detected. ANOVA: NP, not performed (because of the wide dispersion of the data); NS, no significant difference; **P < 0.01,
***P < 0.001. Means in the same column not folowed by the same superscript letter differ significantly (P < 0.05).
unpublished). This suggests that low levels of Bacteroides-
like bacteria in feces might be an intrinsic characteristic to
our subject community. However, this conclusion should
be taken with caution given the small number of individ-
uals analyzed.
Ammonium is considered an undesirable bacterial
metabolite associated with protein degradation with
tumor-promoting action in animal models (5, 19). The
literature contains little information of fecal ammonium
concentrations (see Refs. 25–27). Moreover, differences
between studies may simply reflect differences in the an-
alytical methods used. But as this compound is strongly
influenced by diet and feces retention time (28, 29), these
two factors may account for the wide spread of the data,
as suggested by Ikeda et al. (25).
A direct comparison of the enzyme activities reported
in this work with others in the literature (25, 30–32) is dif-
ficult given the different methodologies used and the semi-
quantitative nature of our results. High standard deviations
for enzyme activities, however, are constantly seen for
β-galactosidase, β-glucuronidase, or urease (25, 30–32).
These activities are affected by dietary changes (31, 32),
but whether they are also affected by changes in microbial
populations is not yet known. The Pearson correlation co-
efficient calculated with the present data was unclear in
this respect (data not shown).
Acetic and butyric acids are thought to be important in
the physiology of the GIT, either as energy sources or in
the prevention of colon cancer (3, 9, 10, 13). SCFAs are
strongly influenced by dietary intake, but the types of mi-
crobial populations from the GIT that contribute to their
concentrations are currently unknown. Fecal concentra-
tions of acetic, propionic, and butyric acids in our study
were within the ranges reported in the literature (9, 10, 25,
27, 33). Moreover, the molar ratios of the three predom-
inant SCFAs obtained in this study were quite similar to
those on the referred reports. However, we could not es-
timate the total SCFAs produced per individual, because
the amount of feces in the samples was not recorded. Fur-
thermore, SCFAs excretion is a dual process involving
production and intestinal absorption.
The statistical analysis of both the microbial and the
biochemical variables showed the differences between
individuals to be statistically significant in most cases.
These data are consistent with those of previous reports
indicating that each individual harbors unique microbial
communities which determine characteristic and unique
metabolic profiles (20–23, 25). Some of the variables stud-
ied in this work are necessarily related, but Pearson’s cor-
relation coefficient for within-individual analysis showed
no clear relationships. This further reflects the complex-
ity of the GIT ecosystem and the great number of factors
that influence it, including microbial and biochemical vari-
ables, environmental variables, and diet- and host-related
factors.
A general picture was produced of the composition
and changes in the cultured microbial populations of the
GIT from some healthy Spanish people. Microbial and
biochemical profiles seemed to be individual-dependent.
Some variables were rather stable over time, whereas oth-
ers varied widely. The results of this work could ultimately
be used in the development of probiotics, prebiotics, and
synbiotics, (by using specific species) and in the study of
their effect on the GIT microbial populations. The data
could also be of help in the comparison of microbial and
biochemical parameters of health and illness stages in
Spanish individuals.
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